Biodexa Pharmaceuticals Files 6-K Report
Ticker: BDRX · Form: 6-K · Filed: Jun 11, 2025 · CIK: 1643918
| Field | Detail |
|---|---|
| Company | Biodexa Pharmaceuticals PLC (BDRX) |
| Form Type | 6-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, foreign-private-issuer, corporate-filing
Related Tickers: BDRX
TL;DR
Biodexa Pharma (BDRX) filed a 6-K, confirming 20-F filing and Cardiff HQ. Standard disclosure.
AI Summary
Biodexa Pharmaceuticals PLC, formerly Midatech Pharma Plc, filed a Form 6-K on June 11, 2025. The filing is a report of a foreign private issuer and indicates the company files annual reports under Form 20-F. The company's principal executive office is located at 1 Caspian Point, Caspian Way, Cardiff, United Kingdom.
Why It Matters
This filing provides routine disclosure for Biodexa Pharmaceuticals PLC as a foreign private issuer, informing investors about their reporting status and corporate information.
Risk Assessment
Risk Level: low — This is a routine disclosure filing (6-K) and does not contain new material financial or operational information.
Key Players & Entities
- Biodexa Pharmaceuticals PLC (company) — Registrant
- Midatech Pharma Plc (company) — Former company name
- June 11, 2025 (date) — Filing date
- 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom (location) — Principal executive office
- Form 20-F (document) — Annual report form
- Form 6-K (document) — Filing type
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the company makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
What is Biodexa Pharmaceuticals PLC's former name?
Biodexa Pharmaceuticals PLC was formerly known as Midatech Pharma Plc, with a date of name change on June 2, 2015.
Where is Biodexa Pharmaceuticals PLC's principal executive office located?
The company's principal executive office is located at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom.
Does Biodexa Pharmaceuticals PLC file annual reports under Form 20-F?
Yes, the filing indicates by check mark that the registrant files annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed on June 11, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 11, 2025 regarding Biodexa Pharmaceuticals Plc (BDRX).